drugset / Trial / NCT00115193

Pegfilgrastim Administered on the Same Day as Chemotherapy in Non-Hodgkin's Lymphoma

NCT00115193 ↗

Phase 2 Completed 77 enrolled Amgen
RandomizedSingle-groupQuadruple-blindTreatment

Summary

The purpose of this study is to provide data on the safety and efficacy of pegfilgrastim when administered on the same day versus the next day of chemotherapy, as measured by the duration of grade 4 neutropenia.

Timeline

Start
2003-02
Primary completion
2005-08
Completion
2005-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pegfilgrastim Protein / enzyme biologic 6 mg —

Indications